American Society of Hematology

Figure 1.

Response did not affect the achievement of either IR milestone at select time points. (A) Percentage of patients who achieved IR (CD4 ≥50 × 106/L) at different time points according to response (1-month P = .53; 2-month P = .12; 3-month P = .08). (B) Percentage of patients who achieved IR (CD4 ≥200 × 106/L) at different time points according to response (1-month P > .99; 2-month P = .33; 3-month P = .26).

Response did not affect the achievement of either IR milestone at select time points. (A) Percentage of patients who achieved IR (CD4 ≥50 × 10⁶/L) at different time points according to response (1-month P = .53; 2-month P = .12; 3-month P = .08). (B) Percentage of patients who achieved IR (CD4 ≥200 × 10⁶/L) at different time points according to response (1-month P > .99; 2-month P = .33; 3-month P = .26).

This Feature Is Available To Subscribers Only